VAUGHAN, Ontario--(BUSINESS WIRE)--Sep 11, 2026--
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European CE Mark approval of SeeLyra, the company’s next generation femtosecond laser. One of the most compact femtosecond platforms available, SeeLyra provides surgeons precision and control when performing laser preparation for premium cataract, LASIK flap and corneal therapeutic surgeries while simultaneously supporting the fast, efficient workflows needed in modern operating rooms (ORs).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910556346/en/
“Building on over 15 years of experience in the femtocataract laser market, our goal was to deliver a platform that provides both enhanced functionality and greater flexibility to the OR,” said Luc Bonnefoy, president, Surgical, Bausch + Lomb. “SeeLyra delivers, helping surgeons achieve the precise preparation and controlled conditions necessary to unlock the full potential of premium cataract surgery without compromising on space or efficiency.”
SeeLyra features integrated tools that provide accuracy and control. Live swept source OCT provides real-time depth-visualization throughout the procedure, helping to reduce variability during docking while enabling precise positioning of laser cuts and visual control during laser application. SeeLyra also retains vital, highly appreciated features of VICTUS ™, the previous-generation Bausch + Lomb femtosecond platform, such as an intuitive user interface designed to streamline setup and adaptability for a wide range of procedures including cataract, LASIK flap and corneal therapeutic treatments.
Compact design and the absence of a fixed patient bed, as well as compatibility with existing bed setups, allows for the flexible positioning and easy transport of SeeLyra across modern, space-constrained OR environments. The absence of a fixed bed also contributes to patient comfort, eliminating the need to switch beds between procedures. An articulating swing arm accommodates surgeons’ preferred orientation for performing surgery.
“Premium surgery success begins with precise surgical preparation of the eye,” said José Manuel Larrosa, MD, University of Zaragoza, Spain. “SeeLyra will help me to achieve this consistently on my terms, while fitting seamlessly and efficiently into our OR space and workflow.”
SeeLyra will be available in Europe on a limited basis in the coming months, with increasing availability expected in 2027. Bausch + Lomb is also in the process of seeking regulatory approvals for SeeLyra in markets around the world, including the United States. Indications and approvals may vary by country.
About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
Forward-looking Statements
This news release may contain forward-looking information and statements within the meaning of applicable securities laws (collectively, “forward-looking statements”). Forward-looking statements may generally be identified by the use of the words “anticipates,” “seeks,” “expects,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “potential,” “pending” or “proposed” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
© 2026 Bausch + Lomb.
LYRA.0001.USA.26
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
NEW YORK (AP) — Two decades after U.S. authorities locked Khalid Sheikh Mohammed away at a military detention center in Cuba, the purported mastermind of the Sept. 11 attacks sometimes seems barely any closer to being put on trial than the day he arrived.
A judge recently set a 2028 date for Mohammed to finally be tried before a military tribunal, but some lawyers predict it will never happen — not that year or any other year. They say the maze of legal issues that arose because Mohammed was tortured following his 2003 capture in Pakistan is too twisted to ever be straightened out.
A fleeting bid to put him on trial in a civilian court in New York City was shouted down years ago over security concerns.
A plea agreement that would have kept Mohammed imprisoned for life, but spared him from a possible execution, began to collapse shortly after it was announced in 2024, and finally died for good last year.
“It’s all contaminated by politics and the lack of accountability on torture,” said Joshua Dratel, an attorney who played a part in assuring that Mohammed has proper legal representation.
In late August, the U.S. military judge who set a June 5, 2028, trial date for Mohammed and three others charged in the Sept. 11 attacks ruled that prosecutors could not use an alleged confession he made to the FBI in 2007. Those statements were deemed tainted because Mohammed was subjected to “enhanced interrogation techniques” overseas, including the simulated drowning technique called waterboarding.
While the ruling was a blow to the prosecution, the U.S. government decided not to appeal, in part because doing so could have further delayed a possible trial.
Meanwhile, Mohammed remains jailed in Guantanamo Bay, where he was brought on Sept. 5, 2006, following more than three years in secret prisons in other countries.
Terry Strada, whose husband, Tom, died at the World Trade Center on Sept. 11, said that she and other people who lost family members still hope a trial will someday happen.
“We very much want to see this come to an end at some point. We do want to see justice served. It’s just as important as 25 years ago,” she said.
But Strada, the national chair of the group 9/11 Families United, also said she would rather have Mohammed rot at Guantanamo Bay indefinitely than get behind a resolution that would involve dropping the death penalty as a possibility. Strada said she worries that if Mohammed is not executed, future U.S. leaders might someday be tempted to swap him for Americans held prisoner elsewhere in the world.
The death penalty, she said, “fits the crime and it would prevent that from ever happening. And that’s important to me.”
Mohammed was captured in Pakistan in 2003, accused of developing and directing the 9/11 attacks, as a leader of the Islamic militant group al-Qaida. Some of the delays in his legal proceedings have stemmed from his treatment after he fell into U.S. control. A U.S. Senate report pointed to his extended torture in CIA custody, including 183 sessions of waterboarding.
For a time in 2009, it seemed Mohammed was headed to New York after then-Attorney General Eric Holder announced plans to try him and four other men charged in the Sept. 11 attacks in a Manhattan courthouse just blocks from the World Trade Center site.
Then-President Barack Obama, who had pledged to close the Guantanamo detention center, said Mohammed would face “the most exacting demands of justice.”
Almost immediately, opposition arose. Some critics predicted Mohammed would use a trial as a platform to spread hateful views of America and its allies. Others cited security concerns, saying it could again make New York a terrorist target. Former New York City Mayor Rudy Giuliani, a Republican, called the plan unwise and said it showed “a lack of concern for the rights of the public.”
Plans for a civilian trial were dropped.
“It was a charade in many respects,” Dratel said.
The military tribunal system, he said, has proven itself to be a worse solution, unable to function efficiently, without a proper structure and without fidelity to federal courts.
“Each time you reach an impasse, no one knows what to do,” he said.
David Raskin, a Washington lawyer now in private practice who would have led the government’s prosecution of Mohammed in New York if it hadn't been abandoned, said in an essay published in The Washington Post on Wednesday that he is confident a civilian trial would have ended with a conviction. The military commissions, on the other hand, “became a defense lawyer's dream,” beset by “endless litigation over their legality and procedures.”
“I predict there will never be a completed military commission trial for Mohammed and the other Sept. 11 defendants,” he said.
An American flag, flowers and an image of Maria Ramirez are left on the 9/11 Memorial, Thursday, September 10, 2026 in New York. (AP Photo/Adam Gray)
People visit the 9/11 Memorial as the sun is reflected off One World Trade Center, Thursday, September 10, 2026 in New York. (AP Photo/Adam Gray)
FILE - A street in New York's lower Manhattan area is littered with debris after the collapse of the twin towers of the World Trade Center following terrorist attacks, Sept. 11, 2001. (AP Photo/Richard Drew File,)
